

Learn about Zelsuvmi side effects, from common skin reactions to rare serious ones. Know what's normal and when to contact your doctor.
Zelsuvmi (berdazimer topical gel, 10.3%) is the first FDA-approved at-home treatment for molluscum contagiosum. Like all medications, it can cause side effects — but most are mild and happen right where you apply the gel.
Understanding what's normal and what's not can help you feel more confident using Zelsuvmi. This guide covers the most common side effects, how to manage them, and the warning signs that mean you should call your doctor.
Zelsuvmi works by releasing nitric oxide directly onto molluscum lesions. Nitric oxide has antiviral properties — it blocks viral proteins, damages viral DNA, and stops the molluscum contagiosum virus from replicating. To learn more about the science, read our guide on how Zelsuvmi works.
Because the gel is applied directly to the skin, most side effects are local skin reactions at the application site. These reactions are actually a sign that the medication is interacting with your skin and the virus beneath it.
In clinical trials, the following side effects were reported by patients using Zelsuvmi:
| Side Effect | How Common |
|---|---|
| Pain, burning, or stinging at the site | 19% of patients |
| Redness (erythema) | 12% of patients |
| Itching (pruritus) | 6% of patients |
| Skin peeling/exfoliation | 5% of patients |
| Rash or dermatitis at the site | 5% of patients |
| Swelling at the site | 3% of patients |
| Fever | 2% of patients |
| Skin discoloration at the site | 1.5% of patients |
| Blisters (vesicles) | 1.5% of patients |
| Vomiting | 1.3% of patients |
This is the most frequently reported side effect. It typically happens right after applying the gel and usually subsides within minutes to an hour.
What you can do:
Some redness around the treated bumps is common and usually mild. It often fades within a few hours after application.
What you can do:
Mild itching at the application site is common. This usually goes away on its own.
What you can do:
Some peeling or flaking of the skin around treated lesions can occur. This is often part of the healing process.
What you can do:
A low-grade fever was reported in a small number of patients, mainly in pediatric clinical trials.
What you can do:
Serious side effects from Zelsuvmi are uncommon, but they can happen. Contact your doctor right away if you experience:
Call your doctor or seek medical attention if:
When in doubt, call. Your doctor would rather hear from you early than deal with a problem that got worse.
Zelsuvmi is approved for patients 1 year of age and older. In clinical trials, side effects in children were similar to those in adults, with application site reactions being the most common.
A few things to keep in mind for pediatric patients:
Most common side effects are temporary — they occur shortly after application and resolve within hours. As your skin adjusts to the medication over the first week or two, side effects often become less noticeable.
Zelsuvmi is used once daily for up to 12 weeks. If side effects persist or worsen after the first two weeks, talk to your doctor. They may adjust your treatment plan.
Zelsuvmi's most common side effects — stinging, redness, and itching — are typical of topical skin treatments and usually mild. Serious side effects are rare. The key is knowing what to expect so you can use the medication confidently and know when to reach out for help.
If you're still deciding whether Zelsuvmi is right for you, check out our guides on what Zelsuvmi is and how to save money on it. And if you're ready to fill your prescription, learn how to check if a pharmacy has Zelsuvmi in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.